CAS 74103-06-3: Ketorolac

Applications Ketorolac is an analgesic; anti-inflammatory. Not a dangerous good if item is equal to or less than 1g/ml and there is less than 100g/ml in the package References Etman, M., et al.: Pharm. Technol., 32, 58 (2008), Chelladurai, S., et al.: Chem. Pharm. Bull., 56, 1596 (2008), Sanderson, H., et al.: Toxicol. Lett., 187, 84 (2009),

5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid - Racemic (5BPC) is a drug that is used for the treatment of pain. It has been shown to be safe and effective in treating postoperative pain when given by intravenous infusion or as an oral tablet. 5BPC has minimal toxicity and is metabolized primarily by the liver with a half life of 2.6 hours. The drug has been found to have pharmacokinetic properties that allow it to be used safely in patients with hepatic impairment and in those recovering from abdominal surgery. 5BPC is a prodrug that undergoes biotransformation by esterases into its active form, pyrrolizidine alkaloid (PA). PA acts as a nonsteroidal anti-inflammatory agent and inhibits prostaglandin synthesis, which leads to analgesia. This drug also has minimal drug interactions because

5-Benzoyl-2,3-dihydro-1h-pyrrolizine-1-carboxylic acid

Ketorolac

Ketorolac is a nonsteroidal anti-inflammatory drug that acts by inhibiting the synthesis of prostaglandins. It is used to control moderate to severe pain, and for reducing postoperative, postpartum and other types of pain. Ketorolac has been shown to be effective in a variety of clinical settings, including those involving hepatic impairment and congestive heart failure. The drug has minimal toxicity and can be used at high doses without adverse effects on the liver or kidney. In addition, ketorolac does not produce significant changes in pge2 levels in experimental models or human serum when administered orally.

Ketorolac (Acuvail) is an NSAID that blocks prostaglandin synthesis, related to heterocyclic acetic acids.